-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Difficult, even the price increase letter can not carry the PA66, it is too difficu.
Difficult, even the price increase letter can not carry the PA66, it is too difficu.
Recently, the global chemical giants Ascend (Ascend) and Basf (BASF) successively issued price increase announcements, all of which point to PA66 full industry chain materials (AND, HMD, adipic acid, AH-salt, e.
Partial translation: On July 15, Ascend announced to raise the prices of PA66 and industrial chain materials, with immediate effect:
Partial translation: On July 15, Ascend announced to raise the prices of PA66 and industrial chain materials, with immediate effect:PA66 rose by 130 euros/ton; HMD rose by 175 euros/ton; AND rose by 175 euros/ton; AN rose by 150 euros/ton; AA rose by 70 euros/t.
PA66 rose by 130 euros/ton; HMD rose by 175 euros/ton; AND rose by 175 euros/ton; AN rose by 150 euros/ton; AA rose by 70 euros/t.
Partial translation: On July 20, BASF announced that it will raise the prices of PA66 and industrial chain materials, which will take effect from August 1:
Partial translation: On July 20, BASF announced that it will raise the prices of PA66 and industrial chain materials, which will take effect from August 1:PA66 rose by 100 euros/ton; AND rose by 100 euros/ton; HMD rose by 100 euros/ton; adipic acid rose by 70 euros/ton; AH-salt rose by euros/t.
PA66 rose by 100 euros/ton; AND rose by 100 euros/ton; HMD rose by 100 euros/ton; adipic acid rose by 70 euros/ton; AH-salt rose by euros/t.
At the key point of the second outbreak of the global epidemic, there were two price increase letters trying to help PA66, which was unexpected; and the two refreshing price increase letters failed to bring obvious momentum to the market, which was even more unexpect.
Adipic acid: The price of products (such as styrene, caprolactam, e.
Downstream: Data will not l.
Summary: Although the two major chemical giants have a strong willingness to pull the price of PA66, PA66 has three contradictions now:
First, it is true that the domestic epidemic prevention and control has achieved a staged victory, and it is true that the recovery of the domestic macro economy still needs a proce.
First, it is true that the domestic epidemic prevention and control has achieved a staged victory, and it is true that the recovery of the domestic macro economy still needs a proce.
Second, the number of confirmed diagnoses in the world is still reaching a new high, the demand in overseas markets is weak, and export-dependent enterprises have not yet escaped the predicame.
Third, the upstream uncertainty is strong, and it cannot lay a solid foundation for the co.
It is expected that in the short term, the PA66 market will hardly see a major improveme.
